N-(4-methoxyphenyl)-2-(thiophene-2-carbonyl)hydrazinecarbothioamide | 209670-94-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(4-methoxyphenyl)-2-(thiophene-2-carbonyl)hydrazinecarbothioamide
• 英文别名: 1-(4-Methoxyphenyl)-3-[[oxo(thiophen-2-yl)methyl]amino]thiourea；1-(4-methoxyphenyl)-3-(thiophene-2-carbonylamino)thiourea
• CAS: 209670-94-0
• 化学式: C₁₃H₁₃N₃O₂S₂
• 分子量: 307.397
• InChiKey: CDMJIFSWLUXAQT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  123
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-(4-methoxyphenyl)-2-(thiophene-2-carbonyl)hydrazinecarbothioamide 在 sodium hydroxide 作用下， 以 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 50.0h， 生成 1-ethyl-6-fluoro-7-(4-((4-(4-methoxyphenyl)-3-(thiophen-2-yl)-5-sulfanylidene-4,5-dihydro-1H-1,2,4-triazol-1-yl)methyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
  参考文献：
  名称：

  1,2,4-三唑-诺氟沙星杂合体的合成、分子对接和抗菌活性评价

  摘要：

  一系列 1,2,4-三唑-诺氟沙星杂化物的设计、合成和体外评价对常见病原体的抗菌活性。所有新合成的化合物均通过傅里叶变换红外分光光度法、质子和碳核磁共振以及电喷雾电离质谱法进行表征。来自每个合成步骤的代表性化合物通过 X 射线晶体学进一步表征。许多合成的化合物对革兰氏阳性菌和革兰氏阴性菌均表现出优于诺氟沙星的抗菌活性。1,2,4-三唑-诺氟沙星杂交体对细菌细胞的毒性比对小鼠成纤维细胞的毒性高 32-512 倍。此外，在 64 μg/mL 的浓度下未观察到溶血，表明具有良好的生物相容性。分子对接显示最小结合能为 -9.4 至 -9.7 kcal/mol，

  DOI：

  10.1016/j.bioorg.2021.105270
• 作为产物：
  描述：

  2-噻吩羧酸乙酯 在 一水合肼 作用下， 以 乙醇 为溶剂， 反应 5.0h， 生成 N-(4-methoxyphenyl)-2-(thiophene-2-carbonyl)hydrazinecarbothioamide
  参考文献：
  名称：

  Synthesis and anti-endoplasmic reticulum stress activity of N-substituted-2-arylcarbonylhydrazinecarbothioamides

  摘要：

  Misfolded or unfolded proteins are accumulated in lumen of endoplasmic reticulum (ER) in ER stress condition. It has been implicated in many pathological conditions such as Alzheimer's disease, diabetic retinopathy, atherosclerosis, beta-cell apoptosis and lung inflammation. We found a series of N-substituted-2-arylcarbonylhydrazinecarbothioamides to potently decrease ER stress signal, showing up to almost 300-fold better activity than 1-hydroxynaphthoic acid and tauro-ursodesoxycholic acid, positive controls, respectively. Structure-activity relationship (SAR) study showed that 2-arylcarbonyl moiety is critical for the activity of the hydrazinecarbothioamide analogues and side chains tethering on thioamide moiety were relatively insensitive to the activity. Some analogues were found to consistently exert the potency under more physiologically relevant condition where ER stress was induced by palmitic acid. ER stress markers such as CHOP and phosphorylated eIF2 alpha and PERK were accordingly decreased in western blotting upon treatment of compound 4h. Potential ER stress inhibitory activity and novel structures could provide a novel platform for new chemical chaperone and therapy for protein misfolding diseases.

  DOI：

  10.1007/s00044-019-02442-1

文献信息

• A Search for Dual Action HIV-1 Reverse Transcriptase, Bacterial RNA Polymerase Inhibitors
  作者：Agata Paneth、Tomasz Frączek、Agnieszka Grzegorczyk、Dominika Janowska、Anna Malm、Piotr Paneth

  DOI：10.3390/molecules22111808

  日期：——

  Using molecular modeling approach, potential antibacterial agents with triazole core were proposed. A moderate to weak level of antibacterial activity in most of the compounds have been observed, with best minimal inhibitory concentration (MIC) value of 0.003 mg/mL, as shown by the 15 against S. epidermidis. Studied compounds were also submitted to the antifungal assay. The best antifungal activity

  使用分子建模方法，提出了具有三唑核的潜在抗菌剂。已观察到大多数化合物具有中等至微弱的抗菌活性，最佳最小抑菌浓度 (MIC) 值为 0.003 mg/mL，如针对表皮葡萄球菌的 15 所示。所研究的化合物也进行了抗真菌试验。对 16 种检测到最佳抗真菌活性，MIC 分别为 0.125 和 0.25 mg/mL，分别对抗白色念珠菌和近平滑念珠菌。
• A new and efficient synthesis of 1,3,4-oxadiazole derivatives using TBTU
  作者：Shokoofeh Maghari、Sorour Ramezanpour、Fatemeh Darvish、Saeed Balalaie、Frank Rominger、Hamid Reza Bijanzadeh

  DOI：10.1016/j.tet.2012.11.071

  日期：2013.2

  An efficient method for the synthesis of 2,5-disubstituted 1,3,4-oxadiazoles from isothiocyanates and hydrazides through cyclodesulfurization in the presence of (O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate) TBTU as an uronium coupling reagent has been developed. The present methodology offers several advantages, such as simple and easy work-up procedures, mild reaction conditions

  用于从异硫氰酸酯和酰肼2,5-二取代的1,3,4-恶二唑，通过环化脱硫中的（存在下合成的有效方法Ô（苯并三唑-1-基） - - ñ，Ñ，N' ，N' -已经开发出四甲基脲鎓四氟硼酸酯（TBTU）作为铀偶联剂。本方法具有几个优点，例如简单和容易的后处理程序，温和的反应条件，并且对环境无害。
• Thiazole compounds and methods of modulating signal transduction
  申请人：Sugen, Inc.

  公开号：US06080772A1

  公开（公告）日：2000-06-27

  The present invention relates to thiazole containing compounds capable of inhibiting protein tyrosine phosphatase activity. The invention further relates to the use of such compounds to modulate or regulate signal transduction by inhibiting protein tyrosine phosphatase activity. Finally, the invention relates to the use of such compounds to treat various disease states including diabetes mellitus.

  本发明涉及含噻唑的化合物，能够抑制蛋白酪氨酸磷酸酶活性。本发明进一步涉及使用这些化合物通过抑制蛋白酪氨酸磷酸酶活性来调节或调控信号传导。最后，本发明涉及使用这些化合物治疗各种疾病状态，包括糖尿病。
• Agonists of the apelin receptor and methods of use thereof
  申请人：Sanford Burnham Prebys Medical Discovery Institute

  公开号：US10570128B2

  公开（公告）日：2020-02-25

  Provided herein are small molecule agonists of the apelin receptor for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions. The present invention is based on the seminal discovery of a series of potent small molecule agonists of the apelin receptor, which are useful for the treatment of diseases including heart failure, chronic kidney disease, hypertension, and metabolic disorders such as insulin resistance/diabetes and obesity. The compounds disclosed herein are highly specific for the apelin receptor versus the angiotensin II receptor (ATI).

  本文提供了用于治疗疾病的阿佩林受体小分子激动剂。本文公开的化合物可用于治疗一系列心血管、肾脏和代谢疾病。本发明基于一系列凋亡素受体强效小分子激动剂的开创性发现，这些激动剂可用于治疗包括心力衰竭、慢性肾病、高血压以及胰岛素抵抗/糖尿病和肥胖症等代谢性疾病。与血管紧张素 II 受体（ATI）相比，本文公开的化合物对阿佩林受体具有高度特异性。
• Searching for novel scaffold of triazole non-nucleoside inhibitors of HIV-1 reverse transcriptase
  作者：Tomasz Frączek、Agata Paneth、Rafał Kamiński、Agnieszka Krakowiak、Piotr Paneth

  DOI：10.3109/14756366.2015.1039531

  日期：——

  Azoles are a promising class of the new generation of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs). From thousands of reported compounds, many possess the same basic structure of an aryl substituted azole ring linked by a thioglycolamide chain with another aromatic ring. In order to find novel extensions for this basic scaffold, we explored the 5-position substitution pattern of triazole NNRTIs using molecular docking followed by the synthesis of selected compounds. We found that heterocyclic substituents in the 5-position of the triazole ring are detrimental to the inhibitory activity of compounds with four-membered thioglycolamide linker and this substitution seems to be viable only for compounds with shorter two-membered linker. Promising compound, N-(4-carboxy-2-chlorophenyl)-2-((4-benzyl-5-methyl-4H-1,2,4-triazol-3-yl)sulfanyl)acetamide, with potent inhibitory activity and acceptable aqueous solubility has been identified in this study that could serve as lead scaffold for the development of novel water-soluble salts of triazole NNRTIs.